Jump to Navigation
Voices: The weird and wonderful ways of SXSW
5 yrs since recession, US markets rebound by more than...
Bouygues Arranges Side Deal
Ackman outspent by Herbalife in lobbying battle
Forward guidance could ‘encourage risk’
Detroit's William Clay Ford Dies At Age 88
Yen Carry Slides In Early Pre-Open Trading
Harper heads to Seoul as critics warn South Korea free-...
BAE report says Ukraine has faced cyberattacks
Giant killers Wigan slay Man City
BioSante CEO Pleased With LibiGel Progress
Biotech Deal Activity Takes a Breather
Biotech Deals Keep Flowing, From Big Pharma to Industrials
Six Trades on FDA, Clinical Trial Binary Events
Biosante: Key Catalysts Should Renew Investor Interest
15 Biotech Stocks With the Lowest Put/Call Ratios
Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer
Is BioSante Pharmaceuticals Next in Line to Receive Institutional Praise?
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
Life Sciences Companies Raise Record Amounts of Capital
Two Biotechs Poised for Gains as Call Options Boost Investor Sentiment
Two Small-Cap Biotechs and a Sector ETF to Keep You Afloat During the Market Correction
Top 24 Small Cap Stocks Being Chased by Smart Money
Biosante Pharma Up After FDA Announces Review of Testosterone Gel
Why BioSante Expects a Positive Review of Drug for Female Sexual Disorder
Platform and Specialty Pharmaceutical Companies Could Strengthen in Face of Big Pharma's Patent Cliff
7 Speculative Healthcare Stocks to Rejuvenate Your Portfolio
6 Prime Biotechs for Short and Long-Term Gains
7 Dirt-Cheap Takeover Targets in Biotech
With Cancer Vaccines in Play, Will Investors Continue to Buy-In?
3 Small Cap Biotech Companies With Future Potential
3 Micro Caps With 50% Upside Potential
Upcoming PDUFA Dates for Sub-$5 Stocks
Friday Options Brief: ADM, TRW, RDWR & BPAX
ROUBINI: 'Bitcoin Is A Ponzi Game And A...
How to Create 5.8 Million Jobs Pronto - Stop...
Create new account
Request new password
Click on the icon to sign in with your social network login or enter your Bullfax.com login
EUR/GBP: 1.2062 USD/EUR: 1.3873 JPY/USD: 102.933
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions